Attached files

file filename
10-K - ANNUAL REPORT - Intra-Cellular Therapies, Inc.f10k2013_oneidaresources.htm
EX-32.1 - CERTIFICATION OF THE COMPANY?S PRINCIPAL EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES OXLEY ACT OF 2002 - Intra-Cellular Therapies, Inc.f10k2013ex32i_oneida.htm
EX-14.1 - CODE OF ETHICS - Intra-Cellular Therapies, Inc.f10k2013ex14i_oneida.htm
EX-31.2 - CERTIFICATION OF THE COMPANY?S PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002, WITH RESPECT TO THE REGISTRANT?S ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED MARCH 31, 2013 - Intra-Cellular Therapies, Inc.f10k2013ex31ii_oneida.htm
EXCEL - IDEA: XBRL DOCUMENT - Intra-Cellular Therapies, Inc.Financial_Report.xls
EX-31.1 - CERTIFICATION OF THE COMPANY?S PRINCIPAL EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002, WITH RESPECT TO THE REGISTRANT?S ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED MARCH 31, 2013 - Intra-Cellular Therapies, Inc.f10k2013ex31i_oneida.htm
Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Annual Report of Oneida Resources Corp. (the "Company") on Form 10-K for the fiscal year ended March 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Samir N. Masri, certify, pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge:

(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
 
/s/ Samir N. Masri
Samir N. Masri
Principal Financial Officer
July 16, 2013